Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Combination Therapy for Treating Advanced Drug-Resistant Acute Lymphoblastic Leukemia.

Vicioso Y, Gram H, Beck R, Asthana A, Zhang K, Wong DP, Letterio J, Parameswaran R.

Cancer Immunol Res. 2019 Jul;7(7):1106-1119. doi: 10.1158/2326-6066.CIR-19-0058. Epub 2019 May 28.

PMID:
31138521
2.

Wheat Germ Agglutinin as a Potential Therapeutic Agent for Leukemia.

Ryva B, Zhang K, Asthana A, Wong D, Vicioso Y, Parameswaran R.

Front Oncol. 2019 Feb 21;9:100. doi: 10.3389/fonc.2019.00100. eCollection 2019.

3.

Hexosamine Biosynthetic Pathway Inhibition Leads to AML Cell Differentiation and Cell Death.

Asthana A, Ramakrishnan P, Vicioso Y, Zhang K, Parameswaran R.

Mol Cancer Ther. 2018 Oct;17(10):2226-2237. doi: 10.1158/1535-7163.MCT-18-0426. Epub 2018 Aug 6.

4.

Activation of Hematopoietic Stem/Progenitor Cells Promotes Immunosuppression Within the Pre-metastatic Niche.

Giles AJ, Reid CM, Evans JD, Murgai M, Vicioso Y, Highfill SL, Kasai M, Vahdat L, Mackall CL, Lyden D, Wexler L, Kaplan RN.

Cancer Res. 2016 Mar 15;76(6):1335-47. doi: 10.1158/0008-5472.CAN-15-0204. Epub 2015 Dec 30.

Supplemental Content

Loading ...
Support Center